Titre:
  • Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
Auteur:Schrijvers, D; van Herpen, C M L; Kerger, Joseph; Joosens, E; Van Laer, C; Awada, Ahmad; Van Den Weyngaert, Danielle; Nguyen Huu, C.; Le Bouder, C; Castelijns, J A; Kaanders, J; de Mulder, Pieter; Vermorken, Jan Baptist
Informations sur la publication:Annals of oncology, 15, 4, page (638-645)
Statut de publication:Publié, 2004-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Cisplatin -- administration & dosage
Cisplatin -- adverse effects
Feasibility Studies
Female
Fluorouracil -- administration & dosage
Fluorouracil -- adverse effects
Head and Neck Neoplasms -- drug therapy
Head and Neck Neoplasms -- mortality
Head and Neck Neoplasms -- pathology
Humans
Male
Middle Aged
Nausea -- chemically induced
Neoplasm Staging
Neoplasms, Squamous Cell -- drug therapy
Neoplasms, Squamous Cell -- mortality
Neoplasms, Squamous Cell -- pathology
Stomatitis -- chemically induced
Survival Analysis
Survival Rate
Taxoids -- administration & dosage
Taxoids -- adverse effects
Thrombocytopenia -- chemically induced
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:pmid/15033673